✦ LIBER ✦

Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials

✍ Scribed by Alessandra Mangia; Gioacchino Leandro; Beat Helbling; Eberhard L Renner; Marco Tabone; Laura Sidoli; Simona Caronia; Graham R Foster; Stephan Zeuzem; Thomas Berg; Vito Di Marco; Nicolina Cino; Angelo Andriulli

Book ID: 116650195
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 207 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2003.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long term follow-up of glycyrrhizin ther

Long term follow-up of glycyrrhizin therapy in patients with chronic hepatitis C and non-response to interferon: Meta-analysis of individual patient data

✍ B.E. Hansen; K. Ikeda; B.J. Veldt; E. Verheij; H. Suzuki; S.W. Schalm 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Clinical trial: a randomized trial of pe

Clinical trial: a randomized trial of pegylated-interferon-α-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

✍ P. LANGLET; F. D’HEYGERE; J. HENRION; M. ADLER; J. DELWAIDE; H. VAN VLIERBERGHE; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Efficacy of interferon-based antiviral t

Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta-analysis of two large prospective clinical trials

✍ François D'Heygere; Christophe George; Hans Van Vlierberghe; Jochen Decaestecker 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract The characteristics and response rate to pegylated interferon and ribavirin (PEG‐INF + RBV) of patients with chronic hepatitis C infected with genotype 5 are poorly documented. A meta‐analysis of two large phase III/IV prospective randomized clinical trials conducted in Belgium in patie

Combination therapy with ribavirin and i

Combination therapy with ribavirin and interferon in naive patients with chronic hepatitis C without virological response after two months of interferon therapy. Preliminary results

✍ F Lunel; P Cresta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Interferon and ribavirin for patients wi

Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials

✍ Steve J. Cheng; Peter A.L. Bonis; Joseph Lau; Nhu Q. Pham; John B. Wong 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB